| 中文名称 | 普卢利沙星 |
|---|---|
| 中文别名 | 普卢利沙星;普利沙星;6-氟-1-甲基-7-[4-(5-甲基-2-氧代-1,3-二氧杂环戊烯-4-基)-甲基-1-哌啶基]-4-氧代-4H-[1,3]硫氮杂环丁烷并[3,2-a]喹啉-3-羧酸;4-(4-氨基苯基)-3-甲基-4-氧代丁酸盐酸盐;Prulifloxacin 普卢利沙星;普卢利沙星(沙星类抗菌药);普卢利沙星-D8;普卢利沙星及其中间体;6-氟-1-甲基-7-{4-(5-甲基-2-氧代-1,3-二噁茂烷-4-基)-甲基-1-哌啶基}-4-氧代-1H,4H-[1,3]噻啶并[3,2-A]-3-喹啉羧酸;沙棘提取;普卢利沙;普利沙星(标准品);普卢利沙星(普利沙星);普卢利沙星溶液, 100PPM;普卢利沙星(研发中);普卢利沙星(-20℃) |
| 英文名称 | Prulifloxacin |
| 英文别名 | 6-Fluoro-1-methyl-7-(4-((5-methyl-2-oxo-1,3-dioxol-4-yl)methyl)piperazin-1-yl)-4-oxo-1,4-dihydro-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid;(+/-)-7-{4-[(z)-2,3-dihydroxy-2-butenyl]-1-piperazinyl}-6-fluoro-1-methyl-4-oxo-1h,4h-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid cyclic carbonate;6-fluoro-1-methyl-7-(4-(5-methyl-2-oxo-1,3-dioxelen-4-yl)methyl-1-piperazinyl)-4-oxo-4h-(1,3)thiazeto(3,2-a)quinoline-3-carboxylic acid;NM441;Prulifloxacin;NM-441;Quisnon;SEA BUCKTHORN P.E;Sword;Pruvel;Prulifloxacine;Prulioxacin-d8;Prulifloxacin (Pruvel);NM 441;Prulifloxacin [INN];AK144730;DSSTox_RID_81651;DSSTox_CID_26480;DSSTox_GSID_46480;1H,4H-(1,3)Thiazeto(3,2-a)quinoline-3-carboxylic acid, 6-fluoro-1-methyl-7-(4-((5-methyl-2-oxo-1,3-dioxol-4-yl)methyl)-1-piperazinyl)-4-oxo-;(+-)-7-(4-((Z)-2,3-Dihydroxy-2;PRULIFLOXACIN 99%;SEA BUCKTHORN P.E 20%;SB18983;PRULIFLOXACIN [WHO-DD];6-fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]piperazin-1-yl]-4-oxo-1H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid;Prulifloxacin (hydrochloride);AF 3012;Prulifloxacin, Antibiotic for Culture Media Use Only;CHEMBL422648;Q3924793;AC-2012;FT-0651733;DB11892;SMR000046722;P2058;HY-B0024;CAS-123447-62-1;MFCD00864847;DTXCID8026480;NCGC00164615-02;SCHEMBL1650794;NCGC00164615-01;NCGC00164615-03;Prulifloxacin, >=98% (perchloric acid titration);MLS006011767;SR-01000872596;PRULIFLOXACIN [JAN];PRULIFLOXACIN [MART.];F20576;BRD-A92341659-001-01-6;OPT-99;AKOS005559236;Prulifloxacin (NM441, AF 3013);(+-)-7-(4-((Z)-2,3-Dihydroxy-2-butenyl)-1-piperazinyl)-6-fluoro-1-methyl-4-oxo-1H,4H-(1,3)thiazeto(3,2-a)quinoline-3-carboxylic acid, cyclic carbonate;SR-01000872596-1;NM441;AF 3013;Tox21_112235;NAD-441A;NS00068018;NSC-759833;Prulifloxacin 100 microg/mL in Acetonitrile;PRULIFLOXACIN [MI];PWNMXPDKBYZCOO-UHFFFAOYSA-N;DTXSID0046480;CCRIS 7686;6-fluoro-1-methyl-7-(4-((5-methyl-2-oxo-1,3-dioxol-4-yl)methyl)piperazin-1-yl)-4-oxo-1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid;AS-13607;CHEBI:32071;BCP12727;GTPL12860;s2071;Tox21_112235_1;NSC 759833;6-fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]piperazin-4-ium-1-yl]-4-oxo-1H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate;Q-101929;J42298IESW;123447-62-1;UNII-J42298IESW;1H,4H-[1,3]Thiazeto[3,2-a]quinoline-3-carboxylic acid, 6-fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]-1-piperazinyl]-4-oxo-;6-fluoro-1-methyl-7-{4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]piperazin-1-yl}-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid;prulifloxacino;(RS)-6-Fluoro-1-methyl-7-[4-(5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl-1-piperazinyl]-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid;prulifloxacinum;SBI-0653843.0001;STK626148;6-Fluoro-1-methyl-7-(4-(5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl-1-piperazinyl)-4-oxo-4H-(1,3)thiazeto(3,2-a)quinoline-3-carboxylic acid;6-Fluoro-1-methyl-7-[4-(5-methyl-2-o... |
| CAS No. | 123447-62-1 |
| 分子式 | C21H20FN3O6S |
| 分子量 | 461.46 |
4-(2-((2R,3R)-3-(2,5-二氟苯基)-3-羟基-4-(1H-1,2,4-三唑-1-基)丁-2-基)噻唑-4-基)苯甲腈
N-(丁基磺酰基)-O-[4-(4-哌啶基)丁基]-L-酪氨酸盐酸盐一水合物
2-(4-(1-羟基-4-(4-(羟基二苯基甲基)哌啶-1-基)丁基)苯基)-2-甲基丙酸
7-环戊基-N,N-二甲基-2-((5-(哌嗪-1-基)吡啶-2-基)氨基)-7H-吡咯并[2,3-d]嘧啶-6-甲酰胺
(1-((2R,3R,4S,5R)-3,4-二羟基-5-甲基四氢呋喃-2-基)-5-氟-2-氧代-1,2-二氢嘧啶-4-基)氨基甲酸戊酯
((3S,5R)-5-((1H-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氢呋喃-3-基)甲基 4-甲基苯磺酸酯
N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-吗啉-4-丙氧基)喹唑啉-4-胺
(6R,7R)-3-甲基-7-[(R)-2-氨基-2-苯乙酰氨基]-8-氧-5-硫杂-1-双环[4.2.0]辛-2-烯-2-甲酸
(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇
(2R,3R,4S,5R)-2-(4-氨基吡咯并[2,1-F][1,2,4]三嗪-7-基)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-甲腈
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用。
CopyRight @2025 广东元丰化学试剂有限公司 版权所有 | 隐私政策 条款及条件 | 粤ICP备2025403430号-1
技术支持:库价化学